Jian Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jian Hu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Di Ma
Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, Jilin, China
1 shared publication - Manman Dou
Department of Neurology, The First Hospital of Jilin University, Changchun 130021, China
1 shared publication - Ying Chen
Department of Neurology The First Hospital of Jilin University Changchun China
1 shared publication - Yingqi Xing
Department of Vascular Ultrasonography, Xuanwu Hospital, Capital Medical University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 4749135
Recent Advancements in CD47 Signal Transduction Pathways Involved in Vascular Diseases
Cardiovascular and cerebrovascular diseases caused by atherosclerosis have a high disability rate and reduce the quality of life of the population. Therefore, understanding the mechanism of atherosclerosis and its control may interfere with the progression of atherosclerosis and thus control the occurrence of diseases closely related to atherosclerosis. TSP‐1 is a factor that has been found to have an antiangiogenic effect, and CD47, as the receptor of TSP‐1, can participate in the regulation of antiangiogenesis of atherosclerosis. VEGF is an important regulator of angiogenesis, and TSP‐1/CD47 can cause VEGF and its downstream expression. Therefore, the TSP‐1/CD47/VEGF/VEGFR2 signal may have an important influence on atherosclerosis. In addition, some inflammatory factors, such as IL‐1 and NLRP3, can also affect atherosclerosis. This review will be expounded focusing on the pathogenesis and influencing factors of atherosclerosis.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 4749135
Open AccessRecent Advancements in CD47 Signal Transduction Pathways Involved in Vascular Diseases
Cardiovascular and cerebrovascular diseases caused by atherosclerosis have a high disability rate and reduce the quality of life of the population. Therefore, understanding the mechanism of atherosclerosis and its control may interfere with the progression of atherosclerosis and thus control the occurrence of diseases closely related to atherosclerosis. TSP‐1 is a factor that has been found to have an antiangiogenic effect, and CD47, as the receptor of TSP‐1, can participate in the regulation of antiangiogenesis of atherosclerosis. VEGF is an important regulator of angiogenesis, and TSP‐1/CD47 can cause VEGF and its downstream expression. Therefore, the TSP‐1/CD47/VEGF/VEGFR2 signal may have an important influence on atherosclerosis. In addition, some inflammatory factors, such as IL‐1 and NLRP3, can also affect atherosclerosis. This review will be expounded focusing on the pathogenesis and influencing factors of atherosclerosis.